San Clemente, CA, July 21, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Global WholeHealth Partners Corp. (OTC PINK:GWHP) announced today that it’s authorized to sell FDA Approved COVID-19 rt-PCR from 1 Drop Inc. Mr. Charles Strongo, the Chairman and CEO of Global WholeHealth Partners Corp, said, “The Company’s goal is to offer the fastest and most reliable in-vitro diagnostic tests on the market, while keeping ahead in R&D, by offering FDA Approved Troponin I Whole Blood, Influenza A & B, and Strep A. The Company also has international testing, which is not sold in the USA, with an FDA Certificate of Exportability #2260-11-2019 for tests like Rapid Ebola, Rapid Dengue Fever Antibody, and Antigen, Rapid Tuberculosis (TB), Rapid Malaria, and many other rapid tests.” The rt-PCR test is a Molecular test for Gene E and Gene RdRp. The COVID-19 is a real-time reverse transcription polymerase chain reaction (rt-PCR) test.  The 2019-nCoV primer and probe set(s) is designed to detect RNA from the 2019-nCoV in sputum and nasopharyngeal swab. Call 1-877-568-GWHP (4947) to become a distributor or buy FDA Approved rt-PCR kits or “Made In The USA” COVID-19 rapid test kits. About Global WholeHealth Partners Corp.: Global WholeHealth Partners Corp. provides cutting   Read more…